NASDAQ Equity Snapshot

ROIV Weekly Equity Report

Roivant Sciences Ltd

Interactive chart JSON snapshot
Latest Close 30.04 USD 12 Jun 2026
1W Return 5.1% latest completed week
4W Return 2.6% short-term follow-through
12W Return 8.4% quarterly tape
Trend Breadth 92.3% 48 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

Roivant Sciences Ltd (ROIV) is a pioneering biopharmaceutical company focused on transforming drug development and commercialization with its innovative business model and cutting-edge technologies. With a diverse pipeline addressing substantial unmet medical needs in areas such as neurology, immunology, and rare diseases, Roivant aims to streamline the drug development process and reduce costs significantly. The company's seasoned leadership and strategic partnerships enhance its ability to navigate the complex healthcare landscape, making it an attractive prospect for institutional investors seeking opportunities that drive both financial returns and improved patient outcomes.

Snapshot

What the weekly tape is saying

ROIV closed the latest completed week at 30.04 USD. The 4-week return is 2.6% and the 12-week return is 8.4%. Trend Signal is active, Market Dynamics is -0.52. Setup signature: Balanced read with a 67/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 15.9%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 96 Persistence of active Trend Signal over the last year and current streak.
Momentum 63 Blend of 4-week and 12-week follow-through.
Dynamics 42 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 36 Participation compared with the 13-week volume baseline.
Risk Control 65 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 2 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
25.91 USD
Vs Trend Line
15.9%
Fair Value
14.29 USD
Vs Fair Value
110.2%
52W High
32.79 USD
52W Low
10.71 USD
Drawdown
-8.4%
Range Position
87.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 5.1%
4W 2.6%
12W 8.4%
26W 35.9%
52W 165.4%

Trend read

Active Streak
48 weeks
52W Active Weeks
48
52W Active Breadth
92.3%
Sector Scope
US Healthcare
Sector Rank
242 of 1032
Sector Percentile
76.6%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.52
4W MD Change
14.4%
Relative Strength
22.82
4W RS Change
-17.2%
Expectation
Positive
Probability
57.60%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
23.6M
13W Average
27.3M
52W Average
32.6M
Vs 13W
0.9x
Vs 52W
0.7x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.2%
52W Volatility
4.5%
Upside Weeks
35
Downside Weeks
17
Downside Breadth
32.7%
Avg Gain / Loss
4.1% / -2.3%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NASDAQ
Country
US
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Market Cap
21.5B

Opportunity signals

  • Trend Signal is active with a 48-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 30.04 USD 5.1% 25.91 USD 14.29 USD -0.52 22.82 23.6M On
5 Jun 2026 28.58 USD -4.7% 25.59 USD 14.16 USD -0.52 20.92 21.7M On
29 May 2026 29.99 USD 0.1% 25.32 USD 14.04 USD -0.43 22.52 28.0M On
22 May 2026 29.96 USD 2.3% 24.99 USD 13.91 USD -0.48 27.37 51.7M On
15 May 2026 29.29 USD 2.6% 24.60 USD 13.78 USD -0.61 27.56 28.5M On
8 May 2026 28.56 USD 2.6% 24.20 USD 13.65 USD -0.38 25.51 20.8M On
1 May 2026 27.83 USD 1.5% 23.78 USD 13.53 USD -0.24 30.45 25.2M On
24 Apr 2026 27.41 USD -8.1% 23.39 USD 13.40 USD -0.05 31.89 29.4M On
17 Apr 2026 29.83 USD 5.7% 22.98 USD 13.28 USD 0.02 48.49 23.1M On
10 Apr 2026 28.21 USD -0.4% 22.49 USD 13.15 USD 0.08 51.27 20.0M On
2 Apr 2026 28.33 USD 6.8% 22.02 USD 13.01 USD 0.28 61.16 22.4M On
27 Mar 2026 26.52 USD -4.3% 21.51 USD 12.88 USD 0.54 59.52 21.4M On
20 Mar 2026 27.70 USD -1.3% 21.02 USD 12.76 USD 0.80 63.90 38.4M On
13 Mar 2026 28.06 USD -2.5% 20.49 USD 12.62 USD 0.80 65.51 31.0M On